EYLEA4U® has support for your patients

EYLEA4U is committed to help ensure your eligible patients have access to EYLEA regardless of insurance or coverage. Our programs include*:

EYLEA4U logo
EYLEA Co-Pay Card Program

With the EYLEA Co-Pay Card,
patients with commercial healthcare coverage may be eligible to pay only the first $5 of each treatment's co-pay.

See the program
Co-Pay Assistance Referral

EYLEA4U can provide
information about the referral process, which connects patients in need to independent charitable foundations.

Learn about the process
Patient Assistance Program

No insurance or no coverage for EYLEA? No problem. The Patient Assistance Program (PAP) from EYLEA4U can provide EYLEA free of charge to your eligible patients.§

Get more information
Did you know? More than 30,000 patients

received support through the EYLEA4U Commercial Co-Pay Support program in 2017.

Find the right co-pay support for your patients

Follow this flowchart to determine how to connect your patients to the right program for help with out-of-pocket costs.

EYLEA out-of-pocket costs flowchart
  • Regeneron does not influence or control the operations of independent charitable foundations and cannot guarantee assistance will be provided.

EYLEA4U Enrollment Form

Complete the EYLEA4U Enrollment Form to begin the process of helping your patients determine co-pay assistance eligibility.

{{DownloadFormModel.OutputFileName}}.zip  {{DownloadFormModel.DownloadSize}} MB
In My Eyes by Regeneron logo

Experience what certain retinal diseases can be like in virtual reality

A powerful tool to use with your patients and caregivers, this unique app lets the user experience retinal disease symptoms firsthand in a 360° view. In My Eyes uses virtual reality and augmented reality to show the impact of vision impairment on everyday situations.

  • Available on the App Store
  • Android app on Google play
Retinal disease virtual and augmented reality app
Product Support

Find complete product support—
guiding you through
orders, returns, and more.

Learn how it works
Reimbursement Support

Get help navigating the
reimbursement process. Find enrollment forms, sample appeal letters, and more.

See the details

Keep up to date on
current EYLEA clinical information,
events, and more.

Read the latest
Important Safety Information and Indications
  • EYLEA® (aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA.
Important Safety Information INDICATIONS

EYLEA® (aflibercept) Injection is indicated for the treatment of patients with Neovascular (Wet) Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR) in patients with DME.

Please see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The information provided in this site is intended only for healthcare professionals in the United States. The products discussed herein may have different product labeling in different countries.